Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
The Leaf Extracts of and Fermented Culture Broths of Synergistically Cause Apoptotic Cell Death in Promyelocytic Leukemia Cells
oleh: Hsin-Ling Yang PhD, Ya-Ting Kuo MS, Yugandhar Vudhya Gowrisankar PhD, Kai-Yuan Lin PhD, Li-Sung Hsu PhD, Pei-Jane Huang PhD, Hui-Chang Lin PhD, You-Cheng Hseu PhD
Format: | Article |
---|---|
Diterbitkan: | SAGE Publishing 2020-07-01 |
Deskripsi
Toona sinensis is a common edible vegetable that is used in certain Chinese dishes and has importance in folk medicine. The leaf extracts of T sinensis possess and exhibit anticancer efficacy against various cancer cell types. In Taiwanese folklore, Antrodia camphorata , also known as “Niu-Cheng-Zi,” is used in traditional medicine to treat various illnesses. Its fruit and mycelium possess various potent antiproliferative properties. Two studies from our group have reported that T sinensis or A camphorata has the ability to cause apoptosis in various cancer cells. Conversely, underlying molecular mechanisms and any beneficial effects remain unknown. This study shows anticancer efficacy for both T sinensis and A camphorata co-treatments that target HL-60 cells. The combination index values indicate that 40 µg/mL of T sinensis and 25 µg/mL of A camphorata as a combined treatment shows a synergetic effect, which reduces HL-60 cell proliferation. Alternately, this treatment exhibited no cytotoxic effects for human umbilical vein endothelial cells. Western blot data showed that T sinensis and A camphorata as a combined treatment result in augmented expression of apoptosis, cytochrome c release, Bcl-2 inhibition, expression of Bax, Fas, and FasL, as well as the cleavage of Bid in HL-60 cells. Moreover, this combined treatment overshadowed monotherapy in its ability to inhibit uPAR, MMP-9, MMP-2, COX-2 expression, and PGE 2 secretions. Our study strongly implies that this combined treatment offers more beneficial effects to suppress and treat leukemia due to apoptosis-mediated cell inhibition. Further in vivo studies related to the combined treatment could establish its future potential.